Maxim Group Maintains Buy on Icecure Medical, Lowers Price Target to $1
Benzinga Newsdesk 5 months ago
NewsPrice TargetAnalyst Ratings
Maxim Group analyst Anthony Vendetti maintains Icecure Medical (NASDAQ:ICCM) with a Buy and lowers the price target from $3 to $1.
Maxim Group analyst Anthony Vendetti maintains Icecure Medical (NASDAQ:ICCM) with a Buy and lowers the price target from $3 to $1.